iCMLf Conversation: CML Highlights of ASH 2022 - Biological overview
iCMLf Conversation: CML Highlights of ASH 2022 - Clinical overview
iCMLf Conversation: CML Highlights of EHA 2022 - Biological and clinical overview
ASH 2022 iCMLf Forum Introduction
iCMLf Conversation: Highlights of the 24th John Goldman E-Conference - Biological overview
CML Highlights of ASH 2023 - Clinical overview
ASH 2022 iCMLf Forum: What's Next?Discussion Panel
ESH CML highlights: the role of metabolism in CML & novel methods to predict response to treatment
ICMLF Conversations - Meet the Expert Q&A Session; Prof Jane Apperley & Prof Giuseppe Saglio
iCMLf Conversation in FRENCH: Update on CML and COVID-19 management
Simona Soverini, PhD, on CML Treatment Advances, Remaining Challenges
Chronic Myeloid Leukemia -2023 Best of Hematology Conference
Day 2 - Virtual Meeting Best of ASH
Conversation on CML: CML and pregnancy
Management of chronic myeloid leukemia: an update
TKI-related toxicities in CML & the importance of long-term monitoring
Treatment Free Remission (TFR) in Clinical Practice
ESH 23rd Annual John Goldman E-Conference on CML: virtual tour of the E-Conference platform
Next Questions: Chronic Myeloid Leukemia
Keynote Goldman Prize 2022: Andreas Hochhaus
